Clinical Trial Update: Efficacy and Safety of Azelastine +Mometasone , Nasal Spray, 140 mcg + 50 mcg, (Sandoz d.d., Slovenia) and Momat Rino Advance, Nasal Spray, 140 mcg + 50 mcg, (Glenmark, India) Administered as a Monotherapy to Patients With Seasonal Allergic Rhinitis. [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the efficacy and safety of Azelastine + Mometasone nasal spray and Momet Rino Advance nasal spray as monotherapy in seasonal allergic …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Rhinitis

Drugs mentioned

• Azelastine + Mometasone nasal spray 140 mcg + 50 mcg (azelastine and mometasone)
• Momat Rino Advance nasal spray 140 mcg + 50 mcg (azelastine and mometasone)

Snippet

Sponsor: Sandoz | Conditions: Seasonal Allergic Rhinitis | Phase 3 | Status: COMPLETED